The role of Nrf2 in the secondary brain injury after intracerebral hemorrhage

doi:10.3969/j.issn.1672-6731.2022.10.002

Abstract

Abstract: Currently, there is still a lack of effective treatment options for intracerebral hemorrhage (ICH). It remains crucial to explore treatment to alleviate the secondary brain injury after ICH and improve the prognosis. Nuclear factor - erythroid 2 - related factor 2 (Nrf2) is the key transcriptional factor during oxidative stress. It also plays an important role in the secondary injury after ICH. This article reviews the regulatory mechanism of Nrf2 and its protective role in the secondary brain injury after ICH, to explore its possibility as a therapentic target.

Key words: Nuclear factor - erythroid 2 - related factor 2 (not in MeSH), Cerebral hemorrhage, Brain injuries, Oxidative stress, Reveiw

摘要： 脑出血的治疗迄今尚未取得突破性进展，如何减轻脑出血继发性损伤、改善患者预后，仍是亟待解决的重要课题。核因子E2相关因子2（Nrf2）作为抗氧化应激过程中关键转录因子，在脑出血继发性损伤的病理生理学机制中发挥重要作用。本文拟就Nrf2调控机制及其在脑出血继发性损伤中保护作用的研究进展进行综述，探讨其作为脑出血治疗靶点的可能性。

XU Wei, XIE Zhi-yi, WANG Ze-xu, MA Lu, YOU Chao, HU Xin. The role of Nrf2 in the secondary brain injury after intracerebral hemorrhage[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2022, 22(10): 836-840.

徐伟, 谢之易, 王泽旭, 马潞, 游潮, 胡鑫. 核因子E2相关因子2对脑出血继发性损伤调控机制研究进展[J]. 中国现代神经疾病杂志, 2022, 22(10): 836-840.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2022.10.002

https://journal11.magtechjournal.com/cjcnn/EN/Y2022/V22/I10/836

References

[1] Ma Q, Li R, Wang L, Yin P, Wang Y, Yan C, Ren Y, Qian Z, Vaughn MG, McMillin SE, Hay SI, Naghavi M, Cai M, Wang C, Zhang Z, Zhou M, Lin H, Yang Y. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2021, 6: e897-906.
[2] Al - Kawaz MN, Hanley DF, Ziai W. Advances approaches for spontaneous intracerebral hemorrhage[J]. Neurotherapeutics, 2020, 17: 1757-1767.
[3] Zhao W, Wu C, Stone C, Ding Y, Ji X. Treatment of intracerebral hemorrhage: current approaches and future directions[J]. J Neurol Sci, 2020, 416: 117020.
[4] Shao Z, Tu S, Shao A. Pathophysiological mechanisms and potential therapeutic targets in intracerebral hemorrhage[J]. Front Pharmacol, 2019, 10: 1079.
[5] Moi P, Chan K, Asunis I, Cao A, Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF - E2 - like basic leucine zipper transcriptional activator that binds to the tandem NF - E2/AP1 repeat of the beta - globin locus control region[J]. Proc Natl Acad Sci USA, 1994, 91: 9926-9930.
[6] Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase Ⅱ detoxifying enzyme genes through antioxidant response elements[J]. Commun, 1997, 236: 313-322.
[7] Yamamoto M, Kensler TW, Motohashi H. The KEAP1 - NRF2 system: a thiol - based sensor - effector apparatus redox homeostasis[J]. Physiol Rev, 2018, 98: 1169-1203.
[8] F?o L, Mota SI, Rego AC. Shaping the Nrf2 - ARE - related pathways in Alzheimer's and Parkinson's diseases[J]. Ageing Res Rev, 2019, 54: 100942.
[9] Liu L, Locascio LM, Doré S. Critical role of Nrf2 in experimental ischemic stroke[J]. Front Pharmacol, 2019, 10: 153.
[10] Wang Y, Xiao CY, Lin HQ, Hu JS, Ip TM, Chi-Cheong Wan D. Development of an enzyme - linked immunosorbent assay for Keap1 - Nrf2 interaction inhibitors identification[J]. Redox Biol, 2020, 34: 101573.
[11] He F, Ru X, Wen T. NRF2, a transcription factor for stress response and beyond[J]. Int J Mol Sci, 2020, 21: 4777.
[12] Chang M, Wilson CJ, Karunatilleke NC, Moselhy MH, Karttunen M, Choy WY. Exploring the conformational landscape of the Neh4 and Neh5 domains of Nrf2 using two different force fields and circular dichroism[J]. J Chem Theory Comput, 2021, 17: 3145-3156.
[13] Nam LB, Keum YS. Binding partners of NRF2: functions and regulatory mechanisms[J]. Arch Biochem Biophys, 2019, 678: 108184.
[14] Jiang H, Li R, Zhang Z, Chang C, Liu Y, Liu Z, He Q, Wang Q. Retinoid X receptor α (RXRα)- mediated erythroid - 2 - related factor - 2 (NRF2) inactivation contributes to N, N - dimethylformamide (DMF) - induced oxidative stress in HL - 7702 and HuH6 cells[J]. J Appl Toxicol, 2020, 40: 470-482.
[15] Tong KI, Katoh Y, Kusunoki H, Itoh K, Tanaka T, Yamamoto M. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two - site molecular recognition model[J]. Mol Cell Biol, 2006, 26: 2887-2900.
[16] Piotrowska M, Swierczynski M, Fichna J, Piechota-Polanczyk A. The Nrf2 in the pathophysiology of the intestine: molecular mechanisms and therapeutic implications for inflammatory bowel diseases[J]. Pharmacol Res, 2021, 163: 105243.
[17] Niino T, Tago K, Yasuda D, Takahashi K, Mashino T, Tamura H, Funakoshi - Tago M. A 5 - hydroxyoxindole derivative attenuates LPS - induced inflammatory responses by activating the p38-Nrf2 signaling axis[J]. Biochem Pharmacol, 2018, 155: 182-197.
[18] Saito R, Suzuki T, Hiramoto K, Asami S, Naganuma E, Suda H, Iso T, Yamamoto H, Morita M, Baird L, Furusawa Y, Negishi T, Ichinose M, Yamamoto M. Characterizations of three major cysteine sensors of Keap1 in stress response[J]. Mol Cell Biol, 2015, 36: 271-284.
[19] Ganner A, Pfeiffer ZC, Wingendorf L, Kreis S, Klein M, Walz G, Neumann - Haefelin E. The acetyltransferase p300 regulates NRF2 stability and localization[J]. Biochem Biophys Res Commun, 2020, 524: 895-902.
[20] Silva - Islas CA, Maldonado PD. Canonical and non - canonical mechanisms of Nrf2 activation[J]. Pharmacol Res, 2018, 134: 92-99.
[21] Cuadrado A. Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β - TrCP[J]. Free Radic Biol Med, 2015, 88(Pt B): 147-157.
[22] Joo MS, Kim WD, Lee KY, Kim JH, Koo JH, Kim SG. AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550[J]. Mol Cell Biol, 2016, 36: 1931-1942.
[23] Park SY, Choi YW, Park G. Nrf2 - mediated neuroprotection against oxygen - glucose deprivation/reperfusion injury by emodin via AMPK - dependent inhibition of GSK-3β[J]. J Pharm Pharmacol, 2018, 70: 525-535.
[24] Lu H, Xiao H, Dai M, Xue Y, Zhao R. Britanin relieves ferroptosis - mediated myocardial ischaemia/reperfusion damage by upregulating GPX4 through activation of AMPK/GSK3β/Nrf2 signalling[J]. Pharm Biol, 2022, 60: 38-45.
[25] Tonelli C, Chio ⅡC, Tuveson DA. Transcriptional regulation by Nrf2[J]. Antioxid Redox Signal, 2018, 29: 1727-1745.
[26] Lee KH, Woo J, Kim J, Lee CH, Yoo CG. Cigarette smoke extract decreased basal and lipopolysaccharide - induced expression of MARCO via degradation of p300[J]. Respirology, 2021, 26: 102-111.
[27] Wang J, Fields J, Zhao C, Langer J, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S, Doré S. Role of Nrf2 in protection against intracerebral hemorrhage injury in mice[J]. Free Radic Biol Med, 2007, 43: 408-414.
[28] Zhao X, Sun G, Zhang J, Strong R, Dash PK, Kan YW, Grotta JC, Aronowski J. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage[J]. Stroke, 2007, 38: 3280-3286.
[29] Sugiyama T, Imai T, Nakamura S, Yamauchi K, Sawada S, Shimazawa M, Hara H. A novel Nrf2 activator, RS9, attenuates secondary brain injury after intracerebral hemorrhage in subacute phase[J]. Brain Res, 2018, 1701: 137-145.
[30] Fu S, Luo X, Wu X, Zhang T, Gu L, Wang Y, Gao M, Cheng Y, Xie Z. Activation of the melanocortin-1 receptor by NDP - MSH attenuates oxidative stress and neuronal apoptosis through PI3K/Akt/Nrf2 pathway after intracerebral hemorrhage in mice[J]. Oxid Med Cell Longev, 2020: 8864100.
[31] Tan X, Yang Y, Xu J, Zhang P, Deng R, Mao Y, He J, Chen Y, Zhang Y, Ding J, Li H, Shen H, Li X, Dong W, Chen G. Luteolin exerts neuroprotection via modulation of the p62/Keap1/Nrf2 pathway in intracerebral hemorrhage[J]. Front Pharmacol, 2020, 10: 1551.
[32] Shi YY, Cui HF, Qin BJ. Monomethyl fumarate protects cerebral hemorrhage injury in rats via activating microRNA-139/Nrf2 axis[J]. Eur Rev Med Pharmacol Sci, 2019, 23: 5012-5019.
[33] Cheng Y, Chen B, Xie W, Chen Z, Yang G, Cai Y, Shang H, Zhao W. Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice[J]. Int Immunopharmacol, 2020, 79: 106180.
[34] Zeng J, Chen Y, Ding R, Feng L, Fu Z, Yang S, Deng X, Xie Z, Zheng S. Isoliquiritigenin alleviates early brain injury after experimental intracerebral hemorrhage via suppressing ROS-and/or NF - κB - mediated NLRP3 inflammasome activation by promoting Nrf2 antioxidant pathway[J]. J Neuroinflammation, 2017, 14: 119.
[35] Hu X, Tao C, Gan Q, Zheng J, Li H, You C. Oxidative stress in intracerebral hemorrhage: sources, mechanisms, and therapeutic targets[J]. Oxid Med Cell Longev, 2016: 3215391.
[36] Bereczki D Jr, Balla J, Bereczki D. Heme oxygenase-1: clinical relevance in ischemic stroke[J]. Curr Pharm Des, 2018, 24: 2229-2235.
[37] Chen - Roetling J, Kamalapathy P, Cao Y, Song W, Schipper HM, Regan RF. Astrocyte heme oxygenase-1 reduces mortality and improves outcome after collagenase - induced intracerebral hemorrhage[J]. Neurobiol Dis, 2017, 102: 140-146.
[38] Yang Y, Xi Z, Xue Y, Ren J, Sun Y, Wang B, Zhong Z, Yang GY, Sun Q, Bian L. Hemoglobin pretreatment endows rat cortical astrocytes resistance to hemin-induced toxicity via Nrf2/HO-1 pathway[J]. Exp Cell Res, 2017, 361: 217-224.
[39] Chen X, Xi Z, Liang H, Sun Y, Zhong Z, Wang B, Bian L, Sun Q. Melatonin prevents mice cortical astrocytes from hemin - induced toxicity through activating PKCα/Nrf2/HO-1 signaling in vitro[J]. Front Neurosci, 2019, 13: 760.
[40] Xi Z, Chen X, Xu C, Wang B, Zhong Z, Sun Q, Sun Y, Bian L. Protocatechuic acid attenuates brain edema and blood - brain barrier disruption after intracerebral hemorrhage in mice by promoting Nrf2/HO-1 pathway[J]. Neuroreport, 2020, 31: 1274-1282.
[41] Chen X, Liang H, Xi Z, Yang Y, Shan H, Wang B, Zhong Z, Xu C, Yang GY, Sun Q, Sun Y, Bian L. BM - MSC transplantation alleviates intracerebral hemorrhage - induced brain injury, promotes astrocytes vimentin expression, and enhances astrocytes antioxidation via the Cx43/Nrf2/HO-1 axis[J]. Front Cell Dev Biol, 2020, 8: 302.
[42] Wei CC, Kong YY, Li GQ, Guan YF, Wang P, Miao CY. Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway[J]. Sci Rep, 2017, 7: 717.
[43] Saito Y, Yako T, Otsu W, Nakamura S, Inoue Y, Muramatsu A, Nakagami Y, Shimazawa M, Hara H. A triterpenoid Nrf2 activator, RS9, promotes LC3 - associated phagocytosis of photoreceptor outer segments in a p62 - independent manner[J]. Free Radic Biol Med, 2020, 152: 235-247.
[44] Bewley MA, Budd RC, Ryan E, Cole J, Collini P, Marshall J, Kolsum U, Beech G, Emes RD, Tcherniaeva I, Berbers GAM, Walmsley SR, Donaldson G, Wedzicha JA, Kilty I, Rumsey W, Sanchez Y, Brightling CE, Donnelly LE, Barnes PJ, Singh D, Whyte MKB, Dockrell DH; COPDMAP. Opsonic phagocytosis in chronic obstructive pulmonary disease is enhanced by Nrf2 agonists[J]. Am J Respir Crit Care Med, 2018, 198: 739-750.
[45] Zhao X, Sun G, Ting SM, Song S, Zhang J, Edwards NJ, Aronowski J. Cleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearance[J]. J Neurochem, 2015, 133: 144-152.
[46] Deng S, Sherchan P, Jin P, Huang L, Travis Z, Zhang JH, Gong Y, Tang J. Recombinant CCL17 enhances hematoma resolution and activation of CCR4/ERK/Nrf2/CD163 signaling pathway after intracerebral hemorrhage in mice[J]. Neurotherapeutics, 2020, 17: 1940-1953.
[47] Wang J, Wang G, Yi J, Xu Y, Duan S, Li T, Sun XG, Dong L. The effect of monascin on hematoma clearance and edema after intracerebral hemorrhage in rats[J]. Brain Res Bull, 2017, 134: 24-29.

Please choose a citation manager

Content to export